FindTrial
Sign In

Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1

Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00078117
Enrollment
516
Registered
2004-02-20
Start date
2003-06-30
Completion date
2005-05-31
Last updated
2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-Related Disorders

Keywords

opiate dependence

Brief summary

The purpose of this protocol is to to compare the clinical utility of two dosage tapering regimens in Buprenorphine/Naloxone stabilized subjects for opiate detoxification.

Interventions

DRUGBuprenorphine

Sponsors

University of California, Los Angeles
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
15 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Females are not pregnant or lactating * Subjects meet DSM-IV criteria for opiate dependence, are medically and psychiatrically stable, and do not have a current history of benzodiazepine dependence abuse, dependence, or treatment

Design outcomes

Primary

MeasureTime frame
Opiate abstinence—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026